A Test of Different Kinds of Bandages on Healing of Wounds

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2013-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This two-week study will compare the healing of minor wounds when no bandage is applied against four different types of bandages.

The study investigators will make five small wounds similar to scrapes (about a half-inch square) on the back of subjects who qualify to participate in the trial and have given informed consent. Four of the wounds will be covered by different bandages and one will be left uncovered. Participants will visit the clinic every day for 2 weeks or until all the wounds are healed (whichever comes first). At the clinic, the bandages will be removed, the doctor will score the wounds, a picture will be taken of the wounds and new bandages will be applied.

It is expected that some pain and itching will be experienced, because they are part of the normal wound healing process. Subjects will be asked about adverse events at each visit and will have the opportunity to discuss issues or concerns with the investigator or the doctor during the course of the trial. It is expected that the wounds will be completely healed within 14 days, but if not, the participant will need to return to the clinic for follow-up treatment until the wounds are completely healed.

We will see if the different bandages help with the healing of the wounds during the study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study to Determine if Fibrin Affects the Ability of a Wound to Heal

NCT01253135

Effect of Test Articles on the Healing of a Wound Artificially Induced by Liquid Nitrogen Spray

COMPLETED PHASE1

A Clinical Study of An Antimicrobial Gauze Dressing

NCT00203489

Wounds

TERMINATED NA

Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers

NCT07089602

Diabetic Foot DFU Diabetic Foot Ulcer +6 more

RECRUITING PHASE4

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers

NCT01656889

Venous Leg Ulcers

COMPLETED PHASE3

Preliminary Testing of New Treatment for Chronic Leg Wounds

NCT01858272

Venous Ulcer

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is evaluating the performance of various bandages on facilitating the healing of induced dermabrasion wounds. To qualify for this study, subjects must meet the inclusion/exclusion criteria within the protocol-specified parameters at both the screening and baseline visits. Once a subject is qualified, five dermabrasion wounds will be created on each subject's back by a licensed physician. Four of the wounds will be covered with four different commercially-available bandages and one wound will be left open to the air to serve as a no treatment control. Treatments and control will be randomized to application site. During this 14-day clinical study, subjects will return to the site for daily evaluations; study bandages will also be replaced daily by study personnel. Adverse events will be observed and collected by querying each subject at each visit, and during any follow-up period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wound Healing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

6660

Five dermabrasion wounds will be created on each subject's back by a licensed physician. Four of the wounds will be covered with four different commercially-available bandages (6660, 4314, 8336 and 4840), and one wound will be left open to the air to serve as a no treatment control (0000). Treatments and control will be randomized to application site.

Group Type ACTIVE_COMPARATOR

6660

Intervention Type DEVICE

At each daily visit, designated study personnel will replace the specific test product on the assigned wound site.

4314

Five dermabrasion wounds will be created on each subject's back by a licensed physician. Four of the wounds will be covered with four different commercially-available bandages (6660, 4314, 8336 and 4840), and one wound will be left open to the air to serve as a no treatment control (0000). Treatments and control will be randomized to application site.

Group Type ACTIVE_COMPARATOR

4314

Intervention Type DEVICE

At each daily visit, designated study personnel will replace the specific test product on the assigned wound site.

8336

Five dermabrasion wounds will be created on each subject's back by a licensed physician. Four of the wounds will be covered with four different commercially-available bandages (6660, 4314, 8336 and 4840), and one wound will be left open to the air to serve as a no treatment control (0000). Treatments and control will be randomized to application site.

Group Type ACTIVE_COMPARATOR

8336

Intervention Type DEVICE

At each daily visit, designated study personnel will replace the specific test product on the assigned wound site.

4840

Five dermabrasion wounds will be created on each subject's back by a licensed physician. Four of the wounds will be covered with four different commercially-available bandages (6660, 4314, 8336 and 4840), and one wound will be left open to the air to serve as a no treatment control (0000). Treatments and control will be randomized to application site.

Group Type PLACEBO_COMPARATOR

4840

Intervention Type DEVICE

At each daily visit, designated study personnel will replace the specific test product on the assigned wound site.

0000

Device: 0000

At each daily visit, designated study personnel will cut out the center pad of the bandage and apply only the adhesive tabs around the assigned wound site.

Other Names:

* Sheer Strips
* BAND-AID® with QuiltVent™ Pad Technology

Five dermabrasion wounds will be created on each subject's back by a licensed physician. Four of the wounds will be covered with four different commercially-available bandages (6660, 4314, 8336 and 4840), and one wound will be left open to the air to serve as a no treatment control (0000). Treatments and control will be randomized to application site.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

6660

At each daily visit, designated study personnel will replace the specific test product on the assigned wound site.

Intervention Type DEVICE

4314

At each daily visit, designated study personnel will replace the specific test product on the assigned wound site.

Intervention Type DEVICE

8336

At each daily visit, designated study personnel will replace the specific test product on the assigned wound site.

Intervention Type DEVICE

4840

At each daily visit, designated study personnel will replace the specific test product on the assigned wound site.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Sheer Strips BAND-AID® with QuiltVent™ Pad Technology Flexible Fabric BAND-AID® with QuiltVent™ Pad Technology Tough Strips® Waterproof BAND-AID® with QuiltVent™ Pad Technology Flat Pad BAND-AID® Dora the Explorer™

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects must be able to read and understand English enough to understand the nature, risk and relevance of the study, read and sign the informed consent document, and follow study instructions
* After being completely informed about the study and being given a chance to have all questions answered, the subject has signed an informed consent document agreeing to:
* comply with lifestyle instructions, including: limiting bandage exposure to water or sunlight, the use of lotions, creams, cosmetics or sunscreens during the study, to allow at least 2 hours between showers and scheduled visits, and the use of contraception
* return to the clinical site for follow-up visits if the wounds are not healed by Day 14
* Subject is determined to be an appropriate participant according to protocol-defined conditions, including among other things, Body Weight and Fitzpatrick Skin Type between I (Always burns easily, never tans) and III (Burns moderately, tans gradually)
* In the opinion of the Investigator, participation in the trial will not compromise the subject's safety or the interpretation of study results

Exclusion Criteria

* Medical condition or history, or use of drugs or treatments that could possibly compromise the safety of the research subject or the interpretation of results, per protocol or in the opinion of the investigator
* Known allergies or hypersensitivity to LATEX, anesthetics, adhesive bandages, wound treatment products or any component present in the test bandages
* Current participation in any other clinical trial or past participation in other clinical trials described in the protocol
* Body mass index (BMI) above 35, and/or Fitzpatrick Skin Type above III
* Pregnant, nursing or planning a pregnancy

Minimum Eligible Age

30 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes